Elocon Patient, Information, Instructions - Mometasone Furoate (nasal spray)

Elocon Patient, Information, Instructions - Mometasone Furoate (nasal spray)

PATIENT INFORMATION

Patients being treated with NASONEX Nasal Spray, 50 µg should be given the following information and instructions. This information is intended to aid in the safe and effective use of this medication. It is not a disclosure of all intended or possible adverse effects. Patients should use NASONEX Nasal Spray, 50 µg at regular intervals (once daily) since its effectiveness depends on regular use. Improvement in nasal symptoms of allergic rhinitis has been shown to occur within 2 days after the first dose. Maximum benefit is usually achieved within 1 to 2 weeks after initiation of dosing. Patients should take the medication as directed and should not increase the prescribed dosage by using it more than once a day in an attempt to increase its effectiveness. Patients should contact their physician if symptoms do not improve, or if the condition worsens. To assure proper use of this nasal spray, and to attain maximum benefit, patients should read and follow the accompanying "Patient’s Instructions for Use" insert carefully.

Patients should be cautioned not to spray NASONEX Nasal Spray, 50 µg into the eyes.

Persons who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or measles, and patients should also be advised that if they are exposed, medical advice should be sought without delay.